Organon & Co (NYSE:OGN)
$ 15.06 0.11 (0.74%) Market Cap: 3.85 Bil Enterprise Value: 11.78 Bil PE Ratio: 2.97 PB Ratio: 7.81 GF Score: 71/100

Organon & Co at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 09:30PM GMT
Release Date Price: $16.2 (-0.61%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it is my pleasure to be hosting this fireside chat with the Organon management today. From the company, we have CEO, Kevin Ali; as well as CFO, Matt Walsh. Kevin and Matt. Happy New Year. Thanks for joining us again today.

I thought, Kevin, maybe just to kick off, it would be interested in just maybe some bigger picture thoughts on the business heading into 2024, and then we'll dive into the specifics of the business from there.

Kevin Ali
Organon & Co. - CEO & Director

Sure. Well, I think, Chris, and thanks for the introduction and for hosting this. I think you saw an -- actually, just yesterday, we had an announcement that we made at JPM, a press release where we essentially did a few things. One is we reaffirmed our guidance for 2023. And also, we said that our cash position is probably going to be a little bit better on the high side in terms of our range for '23. And then we kind of gave a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot